Moving to SOHO results. Q3 2023 revenue of $40.1 million, a decrease of $2.7 million or 6.2% over the prior comparable period. This decrease was driven by an anticipated decline in our base offset by the impact of price increases in the period. This was the hardest comparable as the price increase had substantial effect in Q3 2022, but there had not yet been a meaningful increase in churn. In addition, as Scott noted, we cut marketing spend where the lifetime value to customer acquisition cost was marginally profitable. The ARPA of $15.31 increased by $0.89 or approximately 6% year-over-year benefiting from the price increase. Churn declined 10 basis points to 3.5% compared to the prior period and pre-price increase levels. Notwithstanding the above 6.2% revenue decline in the quarter the full-year SoHo revenue decline is benefiting from the first half performance of a negative 3% and expect it to improve ending the year within our 2% to 4% guidance range.
Moving to Q3 consolidated results. Revenue of $90.6 million is a decrease of $1.2 million or 1.3% over Q3 2022. Adjusted EBITDA of $47.5 million was a decrease of $1.6 million over Q3 2022 or 3.2% delivering a 52.5% margin. The main drivers are the revenue fall through mentioned above the plan employing costs, timing of bad debt expenses, while managing costs to keep EBITDA margins within the 50% to 55% guidance expectations. The Q3 2023 non-GAAP tax rate and share count was 19.1% and 19.7 million shares, respectively. Note we repurchased 152,000 shares in the quarter and approximately 500,000 shares year-to-date. Adjusted non-GAAP net income $29.7 million increased $1.1 million or 3.7% driven by the benefits of interest income of $1.5 million, non-cash revaluation of intercompany accounts of $0.7 million and a lower effective tax rate.
Non-GAAP EPS of $1.51 was better than the prior comparable year by 5.6% or $0.08. We continue to build our cash position ending the quarter with a record $156 million in cash and cash equivalents which is sufficient to fund our operations and debt. Q3 was a record post-spin full fiscal quarter free cash flow of $49.9 million. Turning to guidance. Q4 2023 guidance range is as follows. Revenues between $87.5 million and $90.5 million with $89 million at midpoint. Adjusted non-GAAP EBITDA between $46.3 million and $48.2 million with $47.4 million at midpoint. Adjusted non-GAAP EPS at $1.15 to $1.19 with $1.17 at midpoint. For the full year guidance is revenues between $362 million and $365 million with $364 million at midpoint. Adjusted non-GAAP EBITDA between $186 million and $188 million with $187 million at the midpoint.
Adjusted non-GAAP EPS at $5.13 to $5.17 with $5.15 at the midpoint. We’re planning to file our Q3 2023 10-Q at market close today November 9. That concludes my formal comments. I’d like to turn the call back to Scott for some final remarks before we move to the Q&A section. Thank you.
Scott Turicchi: Thank you, Jim. Before we begin our Q&A session I would like to take the opportunity to talk about a management transition noted in our press release. John Nebergall, our Chief Operating Officer will step down from this position effective December 31. John will continue as a strategic advisor in 2024 as he relocates and travels the world. I want to thank John for his more than five years of service to the business. He was hired in mid-2018 to grow the business, focus the opportunity on the healthcare sector and build-out our management team. As part of that build-out he hired Johnny Hecker who will become our Chief Revenue Officer effective January 1, 2024 as well as the EVP of Operations. I would ask Johnny to join us now for the Q&A and I’ll turn it over to the operator to instruct you how to queue for questions.
Operator: Thank you. We will now be conducting a question-and-answer session [Operator Instructions] We did have a question come from Jon Tanwanteng from CJS Securities. Jon, your line is live.
Pete Lukas: Hi. Good afternoon. It’s Pete Lukas for Jon. I guess just in terms of the VA rollout how much do you think you can gain from that plan next year on a gross revenue basis or however you want to define it? How should we think about that?
